West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced it will present an educational seminar on the value of plastic caps for injectable drug vial closure at CPhI Worldwide 2017, taking place October 24-26, 2017 in Frankfurt, Germany. West will also showcase high-quality packaging components and drug delivery solutions, including NovaPure® components, LyoSeal caps and the SmartDose® platform during the industry tradeshow.
“As a leader in the integrated containment and delivery of injectable medicines, West is uniquely positioned to offer dynamic solutions that directly address some of the biggest challenges in the industry, including ensuring quality, sterility and efficacy of packaging components and delivery systems,” said Mike Schaefers, Vice President and General Manager, Global Pharma at West. “These products play a vital role in keeping injectable therapies safe and effective for patients. At CPhI Worldwide, we look forward to sharing the advanced packaging and delivery solutions that West has to offer with pharmaceutical and biopharmaceutical companies from around the world to help them improve the delivery of care to patients.”
Sylvia Marzotko, Senior Manager, Global Product Management, Vial, Containment & Delivery at West, will present an educational session on industry trends driving the adoption of plastic caps as an alternative to aluminum seals in injectable drug packaging:
Emergence of Plastic Caps – Market Drivers and Key Considerations for Assessment
October 25, 1:35 – 2:05 p.m.
Marzotko will discuss the growing market need for innovation in sealing solutions for injectable drug vials and present an overview of key assessment criteria for evaluating when, how and where plastic caps can be a viable solution in current pharmaceutical fill-finish processes.
Additionally, West will feature the following technologies at booth #42G30:

• NovaPure® components—high-quality components for higher-volume pre-filled delivery systems designed using Quality by Design (QbD) principles to reduce particulate and ensure consistency of delivery.
• LyoSeal cap—an all-plastic, instant-sealing solution for lyophilized drug products designed to minimize risk associated with established lyophilization processes while maintaining the necessary sealing requirements.
• SmartDose® platform—A wearable, subcutaneous injector with an integrated drug delivery system that incorporates human factors and usability testing to deliver a truly patient-centric approach to self-administration.